GlassScriptPhysician profile
Jay S Ellis
NPI 1972535524
$10,332.73
in general payments reported to CMS, 2019-2025
48 companies · $953 in 2025
The $953 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,823 · 2020: $1,401 · 2021: $1,674 · 2022: $1,954 · 2023: $716 · 2024: $813 · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,482.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,511.42 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $720.32 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $706.49 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $455.40 | 2019-2024 | Belbuca, Xtampza |
| Nevro Corp. | $396.94 | 2019-2023 | Senza |
| Medtronic, INC. | $339.48 | 2021-2025 | Catalyft Pl Expandable Interbody System, Intellis Adaptivestim |
| Medtronic USA, INC. | $309.45 | 2019 | |
| Scilex Pharmaceuticals INC. | $214.72 | 2020-2023 | Ztlido |
| Averitas Pharma INC. | $191.05 | 2023-2025 | Qutenza |
| Eagle Pharmaceuticals, INC. | $125.00 | 2019 | |
| Stimwave Technologies Incorporated | $111.74 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.59 | 2020-2025 | Relistor |
| Vertos Medical, INC. | $83.83 | 2024 | Mild Device Kit |
| Globus Medical, INC. | $69.39 | 2025 | Vyrsa V1, Senza |
| Novartis Pharmaceuticals Corporation | $62.79 | 2019-2020 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.